FDA Import Refusal AEK-3459205-3/11/1 — Crescent Pharma Ltd

Crescent Pharma Ltd — FEI 3005848698

The FDA refused shipment AEK-3459205-3/11/1 from Crescent Pharma Ltd (United Kingdom) on Jul 3, 2023. The refused product falls under Drugs and Biologics — METOCLOPRAMIDE HCL (ANTI-EMETIC/NAUSEANT). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal details

Date
Jul 3, 2023
Country
United Kingdom
Product Category
Drugs and Biologics
Product Code
61TDY12 METOCLOPRAMIDE HCL (ANTI-EMETIC/NAUSEANT)
Charges
75

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.